Mithramycin therapy in advanced testicular neoplasms.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001806:Blood Urea Nitrogen; D005500:Follow-Up Studies; D006801:Humans; D007275:Injections, Intravenous; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy; D011517:Prothrombin Time; D013724:Teratoma / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*
D000903:Antibiotics, Antineoplastic; D007770:L-Lactate Dehydrogenase